baber/WOPTO huggingface dataset:
Patent FI-970826-A0 (FI)
Inventor: HODSON MARK
IPC: D21F7/08
Filed: 1997-02-27
Abstract: A papermakers fabric (10) is woven from machine direction yarns (11, 19, 20) and one or more layers of cross machine direction yarns (12-18). The cross machine direction yarns (12-18) in at least one of the layers comprise relatively large (12, 13, 16, 17) and small (14, 15, 18) yarns. The machine and cross machine direction yarns (11, 19, 20) are arranged such that the machine direction yarns (11, 19, 20) define outer floats or knuckles at the surfaces of the fabric and inner floats or knuckles in the body of the fabric around small cross machine direction yarns (14, 15, 18) provided in one of the cross machine direction yarn layers. The parts of the machine direction yarns provided at one surface defining the inner floats or knuckles do not extend to the plane of the obverse surface of the fabric.
Patent FI-974533-A0 (FI)
Inventor: SAARI JARMO
IPC: H04M15/00
Filed: 1997-12-16
Abstract: It is a problem with telecommunication equipment, such as a telephone exchange, that the counters produce so much information that the processes, such as statistic, traffic management and charging, do not have the time to process them. The system according to the invention includes two main blocks: the first main block is formed by one or more report request service blocks (21) and the second main block (22) is formed by one or more counter service blocks, each of which monitors one or more counters (c1, . . . , cn). The report request service block relays a start-up message (23) to those counter service blocks (e.g. 24) from which it needs counter information. The conditions on which the counter information is desired are stated in the message. The condition may be exceeding/falling short of a given threshold value or the condition may be a timetable, e.g. a time slot, in accordance with which the counter value is to be stated. When the given condition is fulfilled, the requested counter service blocks will read the counter values, locate them in a brief message, each value in its own message, and send the message to the report request service block (21).
Patent IL-59295-A0 (IL)
Title: Dehydropeptide compounds,their production and pharmaceutical compositions containing them
IPC: C07K5/065
Filed: 1980-02-04
Abstract: This invention relates to dehydropeptides containing a tryptophan moiety useful as tumour-resolving and/or histolytic medicaments. Also included in the invention are methods for the preparation of said dehydropeptides, compositions containing said dehydropeptides and methods for the use of said dehydropeptides and dehydropeptide compositions.
Patent IL-62385-A0 (IL)
Title: Preparation of chlorinated derivatives of benzoxazolone
IPC: C07D263/58
Filed: 1981-03-16
Abstract: Process for the preparation of optionally hydroxymethylated 6-chlorobenzoxazolone, which consists in chlorinating and, if appropriate, hydroxymethylating benzoxazolone in a mixture of water and dioxane.
Patent IL-63697-A0 (IL)
Title: Optically active isomers of trans-3(2-chloro-2-(4-chlorophenyl)-vinyl)-2,2-dimethyl-cyclopropane-1-carboxylic acid alpha-cyano-4-fluoro-3-phenoxy benzyl ester,their preparation and their use as ectoparasiticides
IPC: A01N53/08
Filed: 1981-08-31
Abstract: The invention relates to optically active isomers of trans-3-(2-chloro-2-(4-chloro-phenyl)-vinyl-2,2-dimethyl-cyclopropane- 1-carboxylic acid  alpha - cyano-4-fluoro-3-phenoxy-benzyl ester of Formula (I), to methods for the preparation of said optically active isomers, to compositions containing said optically active isomers and to the use of said optically active isomers and compositions for their ectoparasiticidal activity.
Patent IL-83286-A0 (IL)
Title: Novel quinolinoxy compounds,a process for their preparation,and their use as antidotes
IPC: C07D215/28
Filed: 1987-07-22
Abstract: Compounds of the formula   <IMAGE> I  in which Rn denotes hydrogen, halogen or alkyl, Z denotes oxygen or sulfur, R1 and R2, independently of one another, denote hydrogen, alkyl, alkoxyalkyl, haloalkyl or phenalkyl, or, together, denote a (optionally substituted) C2-C4-alkylene bridge, and R3 denotes hydrogen or alkyl, are effective antidotes for protecting crop plants against phytotoxic side effects of herbicides.
Patent AU-PQ942200-A0 (AU)
Title: Roof anchor method and apparatus
IPC: H01Q1/12
Filed: 2000-08-15
Abstract: A method is provided for mounting a roof anchor (10) on a roof support structure (30) having an underside surface (32), the roof fully or partially covered with roof covering material (39), the roof anchor (10) including an attachment means (12) and a shaft (14), the method including the steps of: a) making a first hole (50) in the covering material (39) and the roof support structure (30), which first hole (50) is capable of receiving the shaft (14); b) forming an aperture (38) in the covering material (39) adjacent the first hole (50) and the roof support structure (30); c) inserting an anchor block (20), having a second hole (22) capable of fixedly engaging the shaft (14), through the aperture (38) and locating the anchor block (20) at the underside surface (32) such that the first and second holes (50, 22) are in registry; and d) inserting the shaft (14) through both the first and second holes (50, 22) whereby to fixedly engage the roof anchor (10) to the anchor block (20), such that the roof anchor (10) is mounted on the roof support structure (30).
Patent FI-20031736-A0 (FI)
Inventor: SMAHL JARMO
IPC: F16L47/16
Filed: 2003-11-27
Abstract: A pipe fitting is made of plastic, such as polysulphone PSU or polyphenylsulphone PPSU. At least one end of the pipe fitting (1) comprises an external thread (2) for connecting the pipe fitting (1) to a mounting element, such as a pipe or a mounting piece, e.g. a tap. The thread (2) comprises a ridge (3). Between the ridges (3) there is a continuous helical groove (4). On the bottom of the groove (4) between the ridges (3) of the thread (2) there are protrusions (5).
Patent FI-20080284-A0 (FI)
Inventor: REIJONEN MIKA TAPIO
IPC: C25B/
Filed: 2008-04-15
Abstract: A synthesis method using polarization of materials by an electric field consists of two electrodes (1 and 4), an insulation layer (2), a dielectric layer (3) where the synthesis takes place, a voltage supply (5), a closed circuit and a synthesis container.
Patent FI-20095123-A0 (FI)
Inventor: HJELT TUOMO
IPC: F16L/
Filed: 2009-02-09
Abstract: The invention relates to a closing mechanism for a flap (5', 5) of coating, the flap being intended for covering and at the same time for closing a split (2', 2) in a pipe section (1', 1) made of mineral wool and provided with a coating (4', 4), comprising that at least part of the mineral wool (3) facing side of the flap (5) of the coating (4) of the pipe section (1) is provided with an adhesive (8), on top of which an unsupported longitudinal fringe portion (9) of the flap (5) has been folded for protection, whereby, after installing the pipe section (1), the flap (5) has its fold (9) openable and the pipe section has its split (2) coverable and at the same time closable by securing the flap (5) by means of the adhesive thereon to the underlying coating layer (4). The invention further relates to a method for manufacturing a closing mechanism for a flap (5', 5) of a coating (4', 4), the flap being intended for covering and at the same time for closing a split (2', 2) in a pipe section (1', 1) provided with the coating (4', 4) and made from a mineral wool (3', 3). This manufacturing method comprises providing at least part of a mineral wool facing side of the pipe section coating flap with an adhesive (8), on top of which an unsupported longitudinal fringe portion (9) of the flap (5) is folded for protection.
Patent IL-102107-A0 (IL)
Title: A-c-b proinsulin,method of manufacturing and using same,and intermediates in insulin production
IPC: C12R1/19
Filed: 1992-06-04
Abstract: The instant invention provides novel molecules derived from the components of proinsulin using recombinant DNA technology. The invention provides molecules of the formula A-C-B wherein A is the A-chain of an insulin species, B is the B-chain of an insulin species and C is a connecting peptide. These molecules possess insulin-like activity and are useful for the treatment of diabetes mellitus, particularly non-insulin dependent diabetes mellitus. These molecules are also useful for the production of insulin and constitute a novel pathway for the recombinant production of insulin species. The invention provides a method of making insulin proceeding through the compounds of the invention as intermediates. The instant invention further provides recombinant DNA compounds which encode the compounds of the invention. <IMAGE>
Patent IL-104171-A0 (IL)
Title: 13-(substituted thio)acetoxymilbemycin derivatives,parasiticidal compositions containing the same,processes for the preparation thereof and methods for protection of plants utilizing the same
IPC: A01N43/90
Filed: 1992-12-18
Abstract: Compounds having the formula (I): <CHEM> in which: R<1> is methyl, ethyl or isopropyl; R<2> is alkyl, aralkyl, cycloalkyl, cycloalkylmethyl, aryl, heterocyclic, or heterocyclic-substituted thio; R<3> is hydrogen, methyl or ethyl; or R<2> together with R<3> is -(CH2)n-, in which n is 3,4 or 5; and A is aromatic heterocyclic; and salts thereof, are valuable agricultural and horticultural anthelmintic, acaricidal and insecticidal agents.
Patent IL-114715-A0 (IL)
Title: Intermediate compounds for ring-substituted 2-amino - 1, 2, 3, 4-tetra-hydronaphthalenes and 3-aminochromanes
IPC: C07C225/20
Filed: 1995-07-24
Abstract: The present invention provides novel ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes which exhibit binding activity at the serotonin 1A receptor and 3-aminochromane intermediates. The pharmaceutical compounds have the formula <CHEM>  in which R is C1-C4 alkyl, allyl, or cyclopropylmethyl; R1 is hydrogen, C1-C4 alkyl, allyl, cyclopropylmethyl, or aryl(C1-C4-alkyl);  R2 is hydrogen or methyl;  X is -CH2- or -O-; R3 is C1-C8 alkyl, aryl, substituted aryl, aryl(C1-C4-alkyl), substituted aryl(C1-C4 alkyl), or C5-C7 cycloalkyl;  n is 0, 1, or 2; and pharmaceutically acceptable acid addition salts thereof.
Patent IL-124802-A0 (IL)
Title: Thermopolastic composition for light-scattering materials
IPC: C08L25/04
Filed: 1998-06-08
Abstract: The composite thermoplastic material, for light diffusion, has a transparent thermoplastic base material. The material contains polyamide particles in an average size of 0.4-200.0 mu m at a level of 20-1000 ppm of the whole composite material content. Also claimed is a light diffuser, of the composite material, with the highest concentration of polyamide particles close to the diffusion surface.
Patent IL-130532-A0 (IL)
Title: Gel composition and methods
IPC: A61K47/14
Filed: 1997-12-18
Abstract: Methods and compositions for systemically or locally administering by implantation a beneficial agent to a subject are described, and include, for example, compositions having burst indices of 8 or less for systemic applications and systems releasing 10% or less of the total dose of beneficial agent in the first 24 hours after implantation for local applications. The compositions include a biocompatible polymer, a biocompatible solvent having low water miscibility that forms a viscous gel with the polymer and limits water uptake by the implant, and a beneficial agent.
Patent IL-134999-A0 (IL)
Title: Method and device for processing tires
IPC: B26D1/00
Filed: 1998-09-10
Abstract: The side walls are cut from the tread, producing rings. Reassembly makes novel products. Independent claims are included for the products described and equipment cutting the tires. The tire (3) is located in a guide and driven by a roller (5). The roller bulges (7) the tire. Cutters (8) on shafts (6) operate from within the distorted tire. Preferred features: The rings are braided together. The new products are planar structures, or three-dimensional. They form mats, strands or blocks. Further cuts along the circumference of the tread ring, forms narrower rings of the same diameter, whilst cutting the side walls similarly, forms rings of differing diameters. The cutting equipment used, is static or mobile. For transport to the equipment, the tires are cut along the tread, forming two stacking, U-section rings. The rubber is placed under tension during cutting.
Patent IL-135699-A0 (IL)
Title: Device for magnetic field therapy
IPC: A61N2/04
Filed: 1998-10-16
Abstract: The arrangement has at least one device for generating a magnetic field with static and alternating components at the position of the tissue being treated. The alternating field has a defined cell biorhythm frequency and is essentially monochromatic. The field is modulated with a frequency defined by Bq/2pi m, where B is the static magnetic flux density, q is the charge and m is the mass of the predefined ion. Alternatively, the field may have a predefined organ biorhythm frequency.
Patent IL-137136-A0 (IL)
Title: Racemization of r,s-dioxo benzylpyrrolopiperidine
IPC: C07D487/04
Filed: 2000-07-03
Abstract: Racemization of (1R,6S)-8-benzyl-7,9-dioxo-2,8-diazabicyclo(4.3.0)nonane (R,S-dioxo-benzylpyrrolopiperidine or R-DOPP, (I)) comprises treatment of the compound with a deficit of base.
Patent IL-140899-A0 (IL)
Title: Lipid/polymer containing pharmaceutical compositions and processes for the preparation thereof
IPC: A61K9/26
Filed: 1999-07-16
Abstract: Pharmaceutical compositions that enable the release of a physiologically active substance over a prolonged period of time following administration to a patient are described. The pharmaceutical compositions are provided by encapsulation of a physiologically active substance into a matrix comprising biodegradable polymers and lipids. The rate of release of the physiologically active substance from the pharmaceutical composition is controlled by varying the ratio of the polymer to the lipid. The compositions can be stored in an aqueous suspension or as a solid dosage form. The physiologically active substances include small molecules, peptides, proteins, nucleic acids and vaccines. The biodegradable polymers include homopolymers, or random or block copolymers. The lipids include phospholipids, cholesterol and glycerides.
Patent IL-141801-A0 (IL)
Title: Methods and compositions for increasing intestinal absorption of fats
IPC: A61K47/24
Filed: 1999-09-07
Abstract: This invention provides a composition and method for increasing fat absorption from the intestine by increasing the amount of lysophosphatidylcholine in the intestine. The composition comprises phospholipase A2 and lipid molecules.
Patent IL-146216-A0 (IL)
Title: Metal immune system
IPC: G01B7/00
Filed: 2001-10-29
Abstract: A method for tracking an object, including producing an unperturbed energy field at a plurality of predetermined frequencies in the vicinity of the object and determining a characteristic of a perturbing energy field induced responsive to the unperturbed field, due to introduction of an article, responsive to the unperturbed field, into the vicinity of the object. The method further includes receiving a plurality of resultant signals responsive to the unperturbed and perturbing energy fields generated at a location of the object after introduction of the article, determining an optimal frequency for the unperturbed energy field from amongst the plurality of predetermined frequencies responsive to a parameter of the resultant signals, and determining spatial coordinates of the object responsive to the resultant signal at the optimal frequency.
Patent IL-147265-A0 (IL)
Title: Delivery system for oral care compositions comprising organosiloxane resins using a removable backing strip
IPC: A61K8/34
Filed: 2000-06-30
Abstract: Disclosed is a composition for delivering an oral care substance to the oral cavity, comprising: (a) an organosiloxane resin; (b) a volatile carrier capable of solubilizing the organosiloxane resin; (c) a rheology modifier; and (d) at least one oral care substance. The present invention is also directed to such compositions comprising: (a) an organosiloxane resin; (b) a fluid diorganopolysiloxane polymer; (c) a volatile carrier capable of solubilizing the organosiloxane resin and the fluid diorganopolysiloxane polymer; (d) a rheology modifier; and (e) at least one oral care substance. Further disclosed is a method of using these compositions.
Patent IL-154995-A0 (IL)
Title: Polypeptide bombesin antagonists, their preparation and pharmaceutical preparations containing them
IPC: C07K7/02
Filed: 2003-03-19
Abstract: Pseudopeptides comprising a peptide of formula I: X-A1-A2-Trp-Ala-Val-Gly-His-Leu-psi-A9-Q wherein X is hydrogen, a single bond linking the alpha amino group of A1 to the gamma carboxyl moiety on the 3-priopionyl moiety of A2 when A2 is Glu, or a group of formula R1CO- wherein R1 is selected from the groups consisting of a) hydrogen, C1-10alkyl, phenyl or phenyl-C1-10-alkyl, p-HI-phenyl, p-HI-phenyl-C1-10-alkyl, naphthyl, naphthyl-C1-10-alkyl, indolyl, indolyl-C1-10-alkyl, pyridyl, pyridyl-C1-10-alkyl, thienyl, thienyl-C1-10-alkyl, cyclohexyl or cyclohexyl-C1-10-alkyl, where HI=F, Cl, Br, OH, CH3 or OCH3; b) N(R2)(R3)-, wherein R2 is hydrogen, C1-10alkyl, phenyl or phenyl-C1-10-alkyl, R3 is hydrogen or C1-10alkyl; c) R4O-, wherein R4 is C1-10alkyl, phenyl or phenyl-1-10-alkyl; A1 is a D- or L- amino acid residue selected from the group consisting of Phe, p-HI-Phe, pGlu, Nal, Pal, Tpi, unsubstituted Trp or Trp substituted in the benzene ring by one or more members selected from the group consisting of F, Cl, Br, NH2 or C1-3alkyl; or A1 is a peptide bond linking the acyl moiety of R1CO- to the alpha amino moiety of A2; A2 is Gln, Glu[-], Glu(Y) or His, wherein [-] is a single bond linking the gamma carboxyl group of A2 when A2 is Glu with the alpha amino group of A1 where X is a single bond, Y is -OR5 or -N(R5)(R6) wherein R5 is hydrogen, C1-3 alkyl or phenyl; R6 is hydrogen or C1-3alkyl; and R7 is hydrogen, C1-3alkyl or -NHCONH2; Leu-ypsi- is a reduced form of Leu wherein the C=O moiety of Leu is instead -CH2- such that the bond of this -CH2- moiety with the alpha amino moiety of the adjacent A9 residue is a pseudopeptide bond; A9 is Tac, MTac, or DMTac; and Q is NH2 or OQ1 where Q1 is hydrogen, C1-10alkyl, phenyl or phenyl-C1-10-alkyl; and the pharmaceutically acceptable acids or salts thereof.
Patent IL-158492-A0 (IL)
Title: Device for exciting a centrally focused reflector antenna
IPC: H01Q1/02
Filed: 2002-04-19
Abstract: An arrangement for feeding a centrally focused reflector antenna includes a waveguide (1), a dielectric field transformer (2) arranged on the waveguide (1) and a mounting platform (3) for a series of modules (8) which is embodied on one end of the waveguide (1). The waveguide (1) is provided with an arrangement for receiving the dielectric field transformer (2) which partially protrudes into the waveguide (1). Preferably, a dielectric support (9) may be provided in the vicinity of the dielectric field transformer (2). The middle of the support has a circular bore (12) whose diameter corresponds to the diameter of the dielectric field transformer (2). The centrally focused reflector antenna can be excited in the focal point thereof in a field-optimum broadband manner.
Patent IL-158606-A0 (IL)
Title: Method and system for efficient access to remote i/o functions in embedded control environments
IPC: G06F13/14
Filed: 2002-05-03
Abstract: A method for accessing I/O devices in embedded control environments is provided, wherein said I/O devices are remotely attached to an embedded microprocessor. By mapping said I/O devices' resources to said microprocessor's address or memory address space, existing device drivers can be reused and the time-to-market capability is greatly improved.
Patent IL-163576-A0 (IL)
Title: Flexible foam padding made from melamine and applications thereof
IPC: B60N2/70
Filed: 2003-02-21
Abstract: The melamine foam padding (7) has a hardness level, measured under ISO 24389 B, of below 300 N, and preferably 160 - 200 N, for 40 per cent indentation force.  Preferred Features: Used for a seat or back cushion, at least 50 per cent of the volume is made up of supple melamine foam, and it can have a comfort layer (8) of a different foam or viscoelastic material and also inserts in the form of springs, pouches of fluid or other foam materials. The foam padding is held inside a cover (2b, 3b) of textile, leather or other decorative material which is fire-resistant.
Patent IL-186014-A0 (IL)
Title: Process for the preparation of 2-azabicyclo[3.3.0] octane-3-carboxylic acid derivatives
Filed: 2007-09-18
Abstract: The present invention is aimed at a process for the preparation of compounds of the general formula (I). The objective process is in this case based on the Michael reaction of compounds of the general formula (III) with compounds of the general formula (IV), with subsequent hydrogenation and cyclization of the intermediates of the formula (II) obtained.
Patent IL-186907-A0 (IL)
Title: 4-(pyridin-3-yl)-2-(pyridin-2-yl)-1,2-dihydro-3h-pyrazol-3-one derivatives as specific hifprolyl-4-hydroxylase inhibitors for treating cardiovascular and haematological diseases
Filed: 2007-10-25
Abstract: The present application relates to novel dipyridyl-dihydropyrazolones, processes for their preparation, their use for treatment and/or prophylaxis of diseases and their use for the preparation of medicaments for treatment and/or prophylaxis of diseases, in particular cardiovascular and hematological diseases and kidney diseases, and for promoting wound healing.
Patent IL-192409-A0 (IL)
Title: Method of preparing polyalkylene oxide carboxylic acids
Filed: 2008-06-24
Abstract: A new method of preparing a tertiary alkyl ester of a polyalkylene oxide is provided. The new method employs milder conditions that avoid the back reaction to the starting polyalkylene oxide. The tertiary alkyl ester of a polyalkylene oxide is then reacted with a suitable acid to produce a polyalkylene oxide acid.
Patent IL-204703-A0 (IL)
Title: Immunogenic composition comprising recombinat vector, recombinat cell, transduced with the recombinat vector and a vector
IPC: A61P31/00
Filed: 2010-03-24
Abstract: The invention relates to an immunogenic composition comprising a recombinant vector  characterized in that  it comprises a polynucleotide comprising the cis-acting central initiation region (cPPT) and the cis-acting termination region (CTS), these regions being of retroviral or retroviral-like origin, said vector comprising in addition a defined nucleotide sequence (transgene or sequence of interest) and regulatory signals of retrotranscription, expression and encapsidation of retroviral or retroviral-like origin, wherein the composition is capable of inducing or of stimulating a cell-mediated response for instance a CTL (Cytotoxic T Lymphocytes) response or a CD4 response, against one or several epitopes encoded by the transgene sequence present in the vector.
Patent RO-128255-A0 (RO)
Title: Gluten-free functional product based on medicinal mineral water and process for preparing the same
Inventor: PASARIN DIANA GEORGIANA
IPC: A23L2/02
Filed: 2012-11-20
Abstract: The invention relates to a gluten-free functional product and to a process for preparing the same. According to the invention, the product comprises medicinal mineral water having a pH of 6.5, carbon dioxide 1606 mg/l, sodium 398.8 mg/l, potassium 11.37 mg/l, calcium 321.4 mg/l, magnesium 306.7 mg/l, silica 53.68 mg/l, ammonium ion 0.74 mg/l, soluble gluten-free fibers, fructose, fruit concentrates, natural flavors, succory, natural dye stuffs and acidifier. The claimed method consists in mixing the fructose with the gluten-free fibers, while stirring, adding the fruit concentrates and flavors, adjusting the pH, adding the dye stuffs, followed by pasteurization.